Scientific Reports (Jul 2021)

Optimized procedures for testing plasma metanephrines in patients on hemodialysis

  • Christina Pamporaki,
  • Aleksander Prejbisz,
  • Robert Małecki,
  • Frank Pistrosch,
  • Mirko Peitzsch,
  • Steffen Bishoff,
  • Petra Mueller,
  • Iris Meyer,
  • Doreen Reimann,
  • Katarzyna Hanus,
  • Andrzej Januszewicz,
  • Stefan R. Bornstein,
  • Simon Parmentier,
  • Carola Kunath,
  • Jacques W. M. Lenders,
  • Graeme Eisenhofer,
  • Jens Passauer

DOI
https://doi.org/10.1038/s41598-021-94104-9
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Diagnosis of pheochromocytomas and paragangliomas in patients receiving hemodialysis is troublesome. The aim of the study was to establish optimal conditions for blood sampling for mass spectrometric measurements of normetanephrine, metanephrine and 3-methoxytyramine in patients on hemodialysis and specific reference intervals for plasma metanephrines under the most optimal sampling conditions. Blood was sampled before and near the end of dialysis, including different sampling sites in 170 patients on hemodialysis. Plasma normetanephrine concentrations were lower (P < 0.0001) and metanephrine concentrations higher (P < 0.0001) in shunt than in venous blood, with no differences for 3-methoxytyramine. Normetanephrine, metanephrine and 3-methoxytyramine concentrations in shunt and venous blood were lower (P < 0.0001) near the end than before hemodialysis. Upper cut-offs for normetanephrine were 34% lower when the blood was drawn from the shunt and near the end of hemodialysis compared to blood drawn before hemodialysis. This study establishes optimal sampling conditions using blood from the dialysis shunt near the end of hemodialysis with optimal reference intervals for plasma metanephrines for the diagnosis of pheochromocytomas/paragangliomas among patients on hemodialysis.